Conferences
3–4 April 2017, Amsterdam, The Netherlands
Probiotics Congress: Europe
RESEARCH, DEVELOPMENT & APPLICATION OF PROBIOTICS AND PREBIOTICS IN HUMAN AND ANIMAL HEALTH
An increasing awareness of the importance of the role different bacterial ecosystems play with regards to human health has led to a surge in research, publications and companies in the microbiome and probiotic space. As changes in our lifestyle and the growth of multi-drug resistant bacterial strains have also increased the need for better solutions and management of chronic and life-threatening illnesses, microbiome and probiotic research is one of the most scientifically important and potentially lucrative avenues to be exploring. There is mounting evidence that selected probiotic strains can confer health benefits to us, especially with regards to digestive diseases and pediatric health. Further research into mechanisms of action for particular strains, large-cohort clinical trials, and compliance with good manufacturing practice and standards will result in the next generation of probiotic products to ultimately advance both patient and animal care.
As part of our worldwide microbiome series we are co-locating the European Probiotics Congress with the 4th European Microbiome R&D and Business Collaboration Forum. Both events will be held on April 3-4, 2017 at the historic Beurs van Berlage Conference Centre in central Amsterdam.
An increasing awareness of the importance of the role different bacterial ecosystems play with regards to human health has led to a surge in research, publications and companies in the microbiome and probiotic space. As changes in our lifestyle and the growth of multi-drug resistant bacterial strains have also increased the need for better solutions and management of chronic and life-threatening illnesses, microbiome and probiotic research is one of the most scientifically important and potentially lucrative avenues to be exploring. There is mounting evidence that selected probiotic strains can confer health benefits to us, especially with regards to digestive diseases and pediatric health. Further research into mechanisms of action for particular strains, large-cohort clinical trials, and compliance with good manufacturing practice and standards will result in the next generation of probiotic products to ultimately advance both patient and animal care.
As part of our worldwide microbiome series we are co-locating the European Probiotics Congress with the 4th European Microbiome R&D and Business Collaboration Forum. Both events will be held on April 3-4, 2017 at the historic Beurs van Berlage Conference Centre in central Amsterdam.
